MedTrace Logo

Plasma Pharmacokinetics of Alkylresorcinol Metabolites; New Candidate Biomarkers for Whole Grain Rye and Wheat Intake

NCT00953836 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 15

Last updated 2009-08-06

No results posted yet for this study

Summary

The purpose of this study is to investigate the kinetics of two known alkylresorcinol metabolites in human subjects after intake of high-fiber rye bread. Whole grain rye is the most abundant source of alkylresorcinols.

Conditions

  • Kinetics of Alkylresorcinol Metabolites

Sponsors & Collaborators

  • Samfundet Folkhälsan

    collaborator UNKNOWN

  • Sigrid Jusélius Foundation

    collaborator OTHER

  • University of Helsinki

    lead OTHER

Principal Investigators

  • Matti J Tikkanen, M.D., prof. · Department of Medicine, University of Helsinki, Helsinki, Finland

Eligibility

Min Age
20 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-03-31
Primary Completion
2009-04-30
Completion
2009-05-31

Countries

  • Finland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00953836 on ClinicalTrials.gov